End-of-day quote
Other stock markets
|
||
- CAD | - |
05-15 | Transcript : MediPharm Labs Corp., Q1 2024 Earnings Call, May 15, 2024 | |
05-15 | MediPharm Labs Q1 Gross Profit, Rise | MT |
Sales 2024 * | 43.84M 31.83M 2.5B | Sales 2025 * | 54.94M 39.88M 3.14B | Capitalization | 30.37M 22.05M 1.73B |
---|---|---|---|---|---|
Net income 2024 * | -8M -5.81M -457M | Net income 2025 * | -3M -2.18M -171M | EV / Sales 2024 * | 0.69 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-3.75
x | P/E ratio 2025 * |
-7.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.47% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 19/04/22 |
Greg Hunter
DFI | Director of Finance/CFO | - | 07/02/21 |
Keith Strachan
PSD | President | - | 30/09/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 31/03/23 |
David Pidduck
CEO | Chief Executive Officer | - | 19/04/22 |
Shelley Martin
BRD | Director/Board Member | - | 21/06/20 |
1st Jan change | Capi. | |
---|---|---|
+41.50% | 6.2B | |
-22.89% | 4.1B | |
+9.36% | 3.41B | |
-19.39% | 2.83B | |
-11.05% | 2.29B | |
+45.24% | 1.93B | |
-7.51% | 1.52B | |
+46.81% | 1.51B | |
-18.04% | 1.49B |